Semaglutide Has Antioxidant Properties That May Protect Against Diabetic Complications | Research

The takeaway

A comprehensive review finds semaglutide possesses significant antioxidant properties beyond its blood sugar-lowering effects, potentially explaining its protective benefits against diabetic complications across multiple organs.

Dual benefit
Semaglutide combines glucose-lowering with antioxidant protection, potentially reducing diabetic complications through two mechanisms

What the researchers found

Semaglutide demonstrates antioxidant properties through multiple molecular pathways, suggesting its clinical benefits in diabetes extend beyond glucose lowering to include direct protection against oxidative damage in various tissues.

Why it matters

If semaglutide fights both hyperglycemia and oxidative stress simultaneously, it provides dual protection against diabetic complications — a benefit that many traditional diabetes drugs do not offer. This may partly explain the drug's cardiovascular and renal benefits seen in large clinical trials.

The numbers in context

Review covers multiple studies demonstrating semaglutide's antioxidant effects across various tissues and disease models.

How the study worked

Comprehensive narrative review of published preclinical and clinical studies examining semaglutide's antioxidant mechanisms and their potential clinical significance.

Who was studied

Review of preclinical and clinical studies on semaglutide's antioxidant properties

What this study cannot tell us

Most antioxidant evidence comes from animal and cell studies. The relative contribution of antioxidant effects versus other mechanisms to clinical outcomes in humans is unclear. Exact molecular pathways still being elucidated.

How to read the evidence

Moderate evidence — comprehensive review synthesizing multiple studies, but most antioxidant data is preclinical rather than from human clinical trials.

When this study was published

Published in 2024, incorporating the latest research on semaglutide's non-glycemic effects.

The bigger picture

The discovery that GLP-1 agonists have antioxidant properties adds another dimension to their therapeutic profile. As these drugs become the backbone of diabetes and obesity treatment, understanding their full range of protective mechanisms helps optimize their clinical use.

Questions still open

Do the antioxidant properties of semaglutide vary between the subcutaneous and oral formulations?
How much of semaglutide's cardiovascular benefit can be attributed to its antioxidant effects versus other mechanisms?
Do newer GLP-1/GIP dual agonists like tirzepatide have even stronger antioxidant properties?

Common questions

Does semaglutide protect my organs beyond lowering blood sugar?

Evidence suggests yes. Semaglutide appears to have direct antioxidant effects that protect tissues from damage caused by free radicals, which is a separate mechanism from its blood sugar-lowering action. This may help explain why semaglutide reduces cardiovascular and kidney risks in clinical trials.

Should I take semaglutide specifically for its antioxidant benefits?

Semaglutide is prescribed for diabetes and weight management, not as an antioxidant. However, its antioxidant properties are an added benefit that may contribute to better overall outcomes, especially for people with diabetes who face high oxidative stress.

Read the original research

Exploring the antioxidant properties of semaglutide: A comprehensive review.

Journal of diabetes and its complications, 38(12), 108906

View on PubMed ↗Publisher’s paper ↗

Citation

Yaribeygi, Habib; Maleki, Mina; Forouzanmehr, Behina; Kesharwani, Prashant; Jamialahmadi, Tannaz; Karav, Sercan; Sahebkar, Amirhossein. (2024). Exploring the antioxidant properties of semaglutide: A comprehensive review.. Journal of diabetes and its complications, 38(12), 108906. https://doi.org/10.1016/j.jdiacomp.2024.108906